InflaRx
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.About IFRX
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab.
IFRX Key Statistics
Stock Snapshot
The current InflaRx(IFRX) stock price is $2.58, with a market capitalization of 181.46M. The stock trades at a price-to-earnings (P/E) ratio of -1.88.
On 2026-05-06, InflaRx(IFRX) stock traded between a low of $1.85 and a high of $2.86. Shares are currently priced at $2.58, which is +39.4% above the low and -9.8% below the high.
The InflaRx(IFRX)'s current trading volume is 18.26M, compared to an average daily volume of 3.37M.
During the past year, InflaRx(IFRX) stock moved between $0.71 at its lowest and $2.86 at its peak.
During the past year, InflaRx(IFRX) stock moved between $0.71 at its lowest and $2.86 at its peak.
IFRX News
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
InflaRx (IFRX) announced new pre-clinical data demonstrating low reactive metabolite formation of izicopan in human liver microsomes. Reactive metabolite format...
Analyst ratings
75%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.